Frye Andrew
SEC CIK 1712314 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | SVP, Pres, APAC | 22.0K | — | — | 2 | 2022-02-10 | 2022-03-02 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
Frye Andrew made no open-market trades at BAX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-04 | 2022-03-02 | BAX | Baxter International | Frye Andrew | SVP, Pres, APAC | A - Grant | $0.00 | +7,432 | 22.0K | +51% | $0 |
| M | 2022-02-14 | 2022-02-10 | BAX | Baxter International | Frye Andrew | SVP, Pres, APAC | A - Grant | $0.00 | +5,460 | 10.5K | +108% | $0 |
Purchase Sale Sale after option exercise All abbreviations